Economic analysis including cost benefit

Cost benefit analysis is often part of Impact Assessment and Value for Money studies. However we also carry out CBAs and cost effectiveness analyses (CEAs) on their own where required. For instance, the team have wide experience in pricing and reimbursement studies in the pharmaceutical sector, demand forecasts and capacity planning studies across a wide range of sectors. Our economic analyses use the best available data, they are cross-checked against existing literature and knowledge and developed from scratch with your particular needs in mind.